The FDA has approved the first over-the-counter tablet that combines acetaminophen with naproxen sodium, and the reason it deserves careful reading is not the convenience. It is that millions of people already take both drugs separately without tracking how much of each they have had.
Tylenol with Naproxen, made by Kenvue, was approved on July 24. Each tablet contains 325 milligrams of acetaminophen and 110 milligrams of naproxen sodium, and the labeled dose is two tablets every 12 hours, delivering 650 milligrams of acetaminophen and 220 milligrams of naproxen sodium per dose.
It is indicated for temporary relief of minor aches and pains from headache, backache, muscular aches, toothache, menstrual cramps, and minor arthritis pain, in adults and children 12 and older.
What Is New and What Is Not
The FDA was precise about the claim, and it is narrower than headlines will suggest. This is the first nonprescription product to pair acetaminophen with naproxen sodium specifically. Combination products pairing acetaminophen with a different NSAID already exist on U.S. shelves.
Neither ingredient is new. The agency noted that both are among the most widely used OTC pain relievers in the country, "each with decades of established use and well-characterized safety profiles."
Kenvue says the combination begins working in under 30 minutes and lasts 12 hours, and that across eight clinical studies it outperformed either ingredient taken alone. Those are the company's characterizations of its own trial program. The data have not been published in a peer-reviewed journal, and Kenvue says results will be presented at medical meetings including PAINWeek 2026. Until then, the efficacy claims rest on the FDA's review rather than on evidence readers, or clinicians, can examine.
The company also cites its own consumer survey finding that 75% of people with persistent pain are dissatisfied with current options. That is marketing research, not clinical evidence.
The FDA framed the approval as aligned with a broader administration initiative to expand over-the-counter availability of drugs. That is context for the policy timing rather than a statement about the product's safety or effectiveness.
The Two Ingredients Carry Different Risks
This matters because the risks do not overlap, which means a single tablet now carries both.
Acetaminophen's principal danger is to the liver. Overdose is the leading cause of acute liver failure in the United States, and the total daily ceiling from all sources is 4,000 milligrams for most adults, with some clinicians advising less for people who drink alcohol regularly or have liver disease. The hazard is rarely a deliberate overdose. It is arithmetic, because acetaminophen appears in hundreds of products including cold and flu remedies, sleep aids and prescription combination painkillers.
Naproxen sodium is a nonsteroidal anti-inflammatory drug, and NSAIDs as a class carry FDA boxed warnings for two distinct problems: an increased risk of heart attack and stroke, and a risk of stomach and intestinal bleeding, ulceration and perforation that can occur without warning and can be fatal. Risk rises with age, with duration of use, and in people with a history of ulcers, gastrointestinal bleeding or cardiovascular disease. NSAIDs can also raise blood pressure, reduce kidney function, and interact with blood thinners, certain blood pressure medicines, and low-dose aspirin regimens.
The labeled doses here are conservative. At 1,300 milligrams of acetaminophen and 440 milligrams of naproxen sodium per day, both fall well within standard OTC limits. The risk is not this product used as directed. The risk is this product used alongside something else.
The Practical Hazard Is Stacking
Picture an ordinary week. Someone takes this tablet for back pain in the morning, a multi-symptom cold medicine in the afternoon that contains acetaminophen, and ibuprofen at night because the back pain returned before the 12 hours were up.
That person has now doubled up on acetaminophen and taken two different NSAIDs, and nothing on any of the three boxes told them the combination was a problem in plain terms.
Combination products make this harder rather than easier, because the second ingredient is easy to forget. Someone who knows to avoid extra acetaminophen may not register that they have also taken an NSAID and should not add ibuprofen, aspirin for pain, or another naproxen product.
The 12-hour interval introduces its own trap. A person whose pain returns at hour eight may take another dose early. With a 12-hour product, doing that twice in a day approaches the limits the label was built around.
The single most useful habit is reading the active ingredients panel on every box, not the brand name on the front.
Who Should Be Cautious and What to Watch For
Some people should not use this product without medical advice, and the list is not short. It includes anyone with a history of stomach ulcers or gastrointestinal bleeding, kidney disease, liver disease, heart failure or established cardiovascular disease, uncontrolled high blood pressure, or an aspirin-sensitive asthma pattern. It includes people taking anticoagulants, corticosteroids, certain antidepressants, other NSAIDs, or daily aspirin for heart protection. Adults over 65 face higher bleeding and kidney risks from NSAIDs generally.
Pregnancy deserves specific mention. The FDA advises against NSAID use from about 20 weeks of gestation onward unless directed by a physician, because NSAID exposure at that stage may cause fetal kidney problems and low amniotic fluid. From roughly 30 weeks, there is additional concern about premature closure of a fetal blood vessel called the ductus arteriosus. Anyone pregnant should ask a clinician before taking this.
Warning signs that warrant prompt medical attention include black or tarry stools, vomiting blood or material resembling coffee grounds, severe or persistent stomach pain, unexplained fatigue with yellowing of the skin or eyes, dark urine, or unusual bruising. Chest pain, shortness of breath, weakness on one side of the body, or slurred speech require emergency care.
Anyone who suspects they have exceeded the acetaminophen limit should contact Poison Control at 1-800-222-1222 rather than waiting for symptoms, because early liver injury produces none.
No one should stop a prescribed pain medication in favor of this product without speaking to the clinician who prescribed it.
What Happens Next
Kenvue has not announced retail availability or pricing. The clinical data are expected at medical congresses later this year, which will allow independent evaluation of the efficacy claims for the first time.
The open questions are how the product is priced against buying the two ingredients separately, whether the label carries adequate warnings against ingredient duplication, and whether combining a 12-hour NSAID with acetaminophen in one tablet changes real-world overdose patterns. Those are questions post market surveillance answers over years, not weeks.
The bottom line: the FDA approved the first OTC tablet combining acetaminophen and naproxen sodium, dosed twice daily. Adults with recurring minor pain who currently take both drugs separately are the group most affected. The reasonable action is to read active ingredient panels on every other medicine in the house before adding this one. The central uncertainty is whether a convenient combination increases accidental double dosing.
Frequently Asked Questions
What exactly was approved?Tylenol with Naproxen, tablets containing 325 mg acetaminophen and 110 mg naproxen sodium, taken as two tablets every 12 hours. It is for adults and children 12 and older.
Is this the first combination pain reliever? It is the first to combine acetaminophen with naproxen sodium. Products combining acetaminophen with other NSAIDs already exist.
What is the biggest risk? Accidentally taking more acetaminophen or more NSAID from other products. Total acetaminophen from all sources should stay under 4,000 mg a day for most adults.
Can I take ibuprofen or aspirin with it? Not without medical advice. It already contains an NSAID, and combining NSAIDs increases bleeding and kidney risk.
Who should avoid it? People with ulcer or GI bleeding history, kidney or liver disease, heart disease or heart failure, uncontrolled hypertension, and those on blood thinners. Adults over 65 should ask a clinician.
Is it safe in pregnancy? Ask a clinician. FDA advises against NSAIDs from about 20 weeks of pregnancy unless a physician directs otherwise.
What if my pain returns before 12 hours? Do not take another dose early. Contact a clinician if a labeled dose is not controlling your pain.
Has the trial data been published? Not yet. Kenvue says results will be presented at medical meetings including PAINWeek 2026.
